BRPI0406580A - Uso de carbamato de (s)-n-etil-n-metil-3-[1-(dimetilamino)etil]-fenil, uso de um ou mais ingredientes ativos e medicamento para a profilaxia de envenenamento por inibidores de colinesterase - Google Patents

Uso de carbamato de (s)-n-etil-n-metil-3-[1-(dimetilamino)etil]-fenil, uso de um ou mais ingredientes ativos e medicamento para a profilaxia de envenenamento por inibidores de colinesterase

Info

Publication number
BRPI0406580A
BRPI0406580A BR0406580-8A BRPI0406580A BRPI0406580A BR PI0406580 A BRPI0406580 A BR PI0406580A BR PI0406580 A BRPI0406580 A BR PI0406580A BR PI0406580 A BRPI0406580 A BR PI0406580A
Authority
BR
Brazil
Prior art keywords
ethyl
dimethylamino
methyl
poisoning
active ingredients
Prior art date
Application number
BR0406580-8A
Other languages
English (en)
Inventor
Franck Becher
Thomas Hille
Frank Theobald
Aharon Levy
Original Assignee
Lohmann Therapie Syst Lts
Israel Inst Biolog Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts, Israel Inst Biolog Res filed Critical Lohmann Therapie Syst Lts
Publication of BRPI0406580A publication Critical patent/BRPI0406580A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

"USO DE CARBAMATO DE (S)-N-ETIL-N-METIL-3-¢1-(DIMETILAMINO)ETIL!-FENIL, USO DE UM OU MAIS INGREDIENTES ATIVOS E MEDICAMENTO PARA A PROFILAXIA DE ENVENENAMENTO POR INIBIDORES DE COLINESTERASE". Carbamato de (S)-N-etil-N-metil-3-¢1-(dimetilamino) etil!-fenil (1) ou um ou mais ingredientes ativos de acordo com a fórmula (2) são usados para a proteção preventiva de indivíduos a partir do envenenamento causado por inibidores de colinesterase.
BR0406580-8A 2003-01-17 2004-01-16 Uso de carbamato de (s)-n-etil-n-metil-3-[1-(dimetilamino)etil]-fenil, uso de um ou mais ingredientes ativos e medicamento para a profilaxia de envenenamento por inibidores de colinesterase BRPI0406580A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10301851A DE10301851A1 (de) 2003-01-17 2003-01-17 Verfahren zur medikamentösen Prophylaxe gegen Vergiftungen durch Cholinesterase-Hemmer, sowie hierfür geeignete Wirkstoffe und Arzneimittel
PCT/EP2004/000289 WO2004064829A1 (de) 2003-01-17 2004-01-16 Verfahren zur medikamentösen prophylaxe gegen vergiftungen durch cholinesterase-hemmer, sowie hierfür geeignete wirkstoffe und arzneimittel

Publications (1)

Publication Number Publication Date
BRPI0406580A true BRPI0406580A (pt) 2005-12-20

Family

ID=32602728

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0406580-8A BRPI0406580A (pt) 2003-01-17 2004-01-16 Uso de carbamato de (s)-n-etil-n-metil-3-[1-(dimetilamino)etil]-fenil, uso de um ou mais ingredientes ativos e medicamento para a profilaxia de envenenamento por inibidores de colinesterase

Country Status (9)

Country Link
US (1) US20060183796A1 (pt)
EP (1) EP1585514A1 (pt)
JP (1) JP2006516267A (pt)
KR (1) KR20050104347A (pt)
CN (1) CN1741800A (pt)
BR (1) BRPI0406580A (pt)
DE (1) DE10301851A1 (pt)
IL (1) IL169687A0 (pt)
WO (1) WO2004064829A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2936150B1 (fr) * 2008-09-19 2013-09-06 Dermathologiques D Uriage Lab Nouvelles compositions dermatologiques protectrices de la peau et des muqueuses
GB0809905D0 (en) * 2008-06-02 2008-07-09 Secr Defence A Transdermal drug delivery device
JP7716111B2 (ja) * 2020-08-31 2025-07-31 ノーベルファーマ株式会社 神経変性疾患の症状の緩和又は治療のための貼付剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74497A (en) * 1985-03-05 1990-02-09 Proterra Ag Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives
AU674130B2 (en) * 1991-09-26 1996-12-12 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Substituted phenserines and phenylcarbamates of (-)- eseroline, (-)-N1-noreseroline, and (-)-N1- benzylnoreseroline; as specific inhibitors of acetylcholinesterase
DE4342173A1 (de) * 1993-12-10 1995-06-14 Lohmann Therapie Syst Lts Pharmazeutische Formulierung zur Prophylaxe bzw. Vorbehandlung einer Vergiftung durch phosphororganische Cholinesterasehemmer
DE4342174C1 (de) * 1993-12-10 1995-05-11 Lohmann Therapie Syst Lts Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung
US5807671A (en) * 1995-01-09 1998-09-15 Yissum Research Development Company Of Hebrew University Of Jerusalem Method of screening for genetic predisposition to anticholinesterase therapy
US6955819B2 (en) * 1998-09-29 2005-10-18 Zars, Inc. Methods and apparatus for using controlled heat to regulate transdermal and controlled release delivery of fentanyl, other analgesics, and other medical substances
AU768331B2 (en) * 1998-11-27 2003-12-11 Sanochemia Pharmazeutika Aktiengesellschaft Use of effectors of the central cholinergic nervous system
US6756385B2 (en) * 2000-07-31 2004-06-29 Pfizer Inc. Imidazole derivatives

Also Published As

Publication number Publication date
JP2006516267A (ja) 2006-06-29
CN1741800A (zh) 2006-03-01
KR20050104347A (ko) 2005-11-02
DE10301851A1 (de) 2004-07-29
WO2004064829A1 (de) 2004-08-05
US20060183796A1 (en) 2006-08-17
IL169687A0 (en) 2007-07-04
EP1585514A1 (de) 2005-10-19

Similar Documents

Publication Publication Date Title
DE60019693D1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
HRP20040996B1 (hr) Tablete visokog sadržaja lijeka
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
PL369108A1 (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
MY141243A (en) Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
PT1506185E (pt) Compostos novos e sua utilizacao
MXPA05007609A (es) Antagonista de un receptor sensible al calcio.
BR0210028A (pt) Agentes antibacterianos
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
BR0212069A (pt) Agentes antidiabéticos orais
BR0306928A (pt) Composições farmacêuticas estáveis compreendendo inibidores de enzimas conversoras de angiotensina (ace)
NO20040153L (no) Synergistisk farmasoytisk kombinasjon for profylakse eller behandling av diabetes
ATE253359T1 (de) Antithrombotische mittel
DK0673376T3 (da) Bicykliske pyrimidinforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som omfatter dem
WO2006042478A8 (fr) Inhibiteurs de petites molecules de la protease principale des coronavirus, leur preparation et utilisation
BRPI0406580A (pt) Uso de carbamato de (s)-n-etil-n-metil-3-[1-(dimetilamino)etil]-fenil, uso de um ou mais ingredientes ativos e medicamento para a profilaxia de envenenamento por inibidores de colinesterase
EP1325903A4 (en) DERIVATIVES OF 2,3-DIPHENYLPROPIONIC ACID OR THEIR SALTS, MEDICAMENTS OR INHIBITORS OF CELL ADHESION CONTAINING THE SAME, AND THEIR USE
IT1317049B1 (it) Composti utili per la preparazione di medicamenti ad attivita'inibitrice della fosfodiesterasi iv.
DE69828522D1 (de) Antithrombotische mittel
BR0206841A (pt) Modificação cristalina de um depsipeptìdeo cìclico com melhor eficácia
NO20055254L (no) Farmasoytisk kombinasjon for behandling av spastisitet og/eller smerte
BRPI0513549A (pt) composições farmacêuticas para o tratamento de leishmaniose
BR0313543A (pt) 2,3-diidro-isoindol-1-onas com atividade de inibição de mao-b

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.